Par Pharmecuticals Stung By Another Suit

Law360, New York (August 17, 2006, 12:00 AM EDT) -- Already facing a mountain of litigation, Par Pharmaceutical Companies Inc. has been hit with another class action lawsuit that accuses the pharmaceutical giant and its top executives of committing securities fraud.

The latest suit was filed in U.S. District Court for the District of New Jersey on Thursday, with the class comprised of individuals who purchased Par stock between April 29, 2004 and July 5, 2006.

The health care goliath stands accused of violating the Securities Exchange Act by issuing a string of “material misrepresentations,” according...
To view the full article, register now.